Common multiple interactions of tricyclic antidepressants and orphenadrine with liver microsomal cytochrome P450 enzymes of the rat

References

• BAST, A. and NORDHOEK, J., 1982, Spectral interactions of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat. Biochemical Pharmacology, 31, 2745–2753.
   PubMed Web of Science ®Google Scholar
• BATT, A.-M., SIEST, G., MAGDALOU, J. and GALTEAU, M.-M., 1992, Enzyme induction by drugs and toxins. Clinica et Chimica Acta, 209, 109–121.
   PubMed Web of Science ®Google Scholar
• BENSOUSSAN, C., DELAFORGE, M. and MANSUY, D., 1995, Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs. Biochemical Pharmacology, 49, 591–602.
   PubMed Web of Science ®Google Scholar
• BOCK, K. W., Lipp, H.-P. and BOCK-HENNIG, B. S., 1990, Induction of drug-metabolizing enzymes by xenobio tics . Xenobiotka, 20, 1101–1111.
   Google Scholar
• BROSEN, K., SICJELBO, E., RASMUSSEN, B. B., POULSEN, H. B. and LOFT, S., 1993, Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochemical Pharmacology, 45, 1211–1214.
   PubMed Web of Science ®Google Scholar
• BURKE, M. D., THOMPSON, S., ELCOMBE, C. R., HALPERT, J., HAAPARANTA, T. and MAYER, R. T., 1985, Ethoxy-, pentoxy and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochemical Pharmacology, 34, 3337–3345.
   PubMed Web of Science ®Google Scholar
• COUTTS, R. T., Su, P. and BAKER, G. B., 1994, Involvement of CYP2D6, CYP3A4 and other cytochrome P-450 isozymes in N-dealkylation reactions .Journal of Pharmacological and Toxicological Methods, 31, 177–186.
   PubMed Web of Science ®Google Scholar
• FRANKLIN, M. R., 1977, Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmacology and Therapeutics, A, 2, 227–245.
   Web of Science ®Google Scholar
• FUJITA, S., MORIMOTO, R., CHIBA, M., KITANI, K. and Suzum, T., 1989, Evaluation of the involvement of a male specific cytochrome P-450 isozyme in senescence-associated decline of hepatic drug metabolism in male rats. Biochemical Pharmacology, 38, 3925–3931.
   PubMed Web of Science ®Google Scholar
• GHAHRAMANI, P., ELLIS, S. W., LENNARD, L. E., RAMSAY, L. E. and TUCKER, G. T., 1997, Cytochromes P450 mediating the N-demethylation of amitriptyline. British Journal of Clinical Pharmacology, 43, 137–144.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1977, Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital and 3-methylcholanthrene-treated rats. Journal of Biological Chemistry, 252, 3970–3979.
   PubMed Web of Science ®Google Scholar
• IMAOKA, S., TERANO, Y. and FUNAE, Y., 1989, Expression of four phenobarbital-inducible cytochrome P-450s in liver, kidney, and lung of rats. Journal of Biochemistry, 105, 939–945.
   PubMed Web of Science ®Google Scholar
• HURWITZ, A., VACEK, J. L., BOTTERON, G. W., SZTERN, M. I., HUGHES, E. M. and JAYARAJ, A., 1991, Mexiletine effects on theophylline disposition. Clinical Pharmacology and Therapeutics, 50, 299–307.
   PubMed Web of Science ®Google Scholar
• KRAMER NIELSEN, K., FLINOIS, J. P., BEAUNE, P. and BROSEN, K., 1996, The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways. Journal of Pharmacology and Experimental Therapeutics, 277, 1659–1664.
   PubMedGoogle Scholar
• LEMOINE, A., GAUTIER, J. C., AZOULAY, D., KIFFE L., BELLOC C., GUENGERICH, F. P., MAUREL, P., BEAUNE, P. and LEROUX, J. P., 1993, Major pathway of imipramine metabolism is catalyzed by cytochrome P-450 1A2 and P-450 3A4 in human liver. Molecular Pharmacology, 43, 827–832.
   Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MADSON, H., KRAMER NIELSEN, K. and BROSEN, K., 1995, Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphism — a population study. British Journal of Clinical Pharmacology, 39, 433–439.
   PubMedGoogle Scholar
• McNEIL, C. M. and MURRAY, M., 1996, Inhibition of microsomal cytochromes P450 in rat liver by the tricyclic antidepressant drug desipramine and its primary oxidized metabolites. Biochemical Pharmacology, 51, 15–20.
   PubMed Web of Science ®Google Scholar
• MURRAY, M., 1992. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline. Molecular Pharmacology 42, 931–938.
   PubMed Web of Science ®Google Scholar
• MURRAY, M. and FIELD, S. L., 1992, Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants. Biochemical Pharmacology, 43, 2065-2071. MURRAY, M. and REIDY, G. F., 1990, Selectivity in the inhibition of mammalian cytochromes P-450 by chemical agents. Pharmacological Review, 42, 85–101.
   Google Scholar
• NELSON D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH 0., COON, M. J., FSTABROOK, R. W., GUNSALUS I. C. and NEBERT D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• OHMORI, S., TAKEDA, S., RIKISHA, T., KIUCHI, M., KANAKUBO, Y. and KITADA, M., 1993, Studies on cytochrome P450 responsible for oxidative metabolism of imipramine in human liver microsomes. Biological and Pharmacological Bulletin, 16, 571–575.
   PubMed Web of Science ®Google Scholar
• OMURA, T. and SATO, R., 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   PubMed Web of Science ®Google Scholar
• ORTIZ DE MONTELLANO, P. R., Mico, B. A., MATHEWS, J. M., KUNZE, K. L., MIWA, G. T. and Lu, A. Y. H., 1981, Selective inactivation of cytochrome P-450 isoenzymes by suicide substrates. Archives of Biochemistry and Biophysics, 210, 717–728.
   PubMedGoogle Scholar
• OTTON, S. V., Wu, D., RUSSELL, T. J., CHEUNG, S. C. and SELLERS, E. M., 1993, Inhibition by fluoxetine of cytochrome P450 2D6 activity. Clinical Pharmacology and Therapeutics, 53, 401–409.
   PubMed Web of Science ®Google Scholar
• Roos, P. H., GoLus -Ciosx, B., KALLWEIT, P., KAUCZINSKI, D. and HANSTEIN, W. G., 1993, Formation of ligand and metabolite complexes as a means for selective quanatitation of cytochrome P450 isozymes. Biochemical Pharmacology, 45, 2239–2250.
   Google Scholar
• Roos, P. H. and MAHNKE, A., 1996, Metabolite complex formation of orphenadrine with cytochrome P450. Biochemical Pharmacology, 52, 73–84.
   PubMedGoogle Scholar
• SCHMIDER, J., GREEBLATT, D. J., VONMOLTKE, L. L., HARmATz, J. S. and SHADER, R. I., 1995, N-Demethylation of amitriptyline in vitro: role of cytochrome P-450 3A (CYP3A. isoforms and effect of metabolic inhibitors. Journal of Pharmacology and Experimental Therapeutics, 275, 592–597.
   PubMed Web of Science ®Google Scholar
• STEVENS, J. C. and WRIGHTON, S. A., 1993, Interaction of the enantiomers of fluoxetine and norfluoxetine with human liver cytochromes P450. Journal of Pharmacology and Experimental Therapeutics, 266, 964–971.
   PubMed Web of Science ®Google Scholar
• VANDEL S., BERTSCHY, G., BAUMANN, P., BOUQUET, S., BONIN, B., FRANCOIS, T., SECHTER, D. and BIZOUARD, P., 1995, Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Pharmacological Research, 31, 347–353.
   Google Scholar
• WATKINS, P. B., WRIGHTON, S. A., SCHUETZ, E.G., MAUREL, P. and GUZELIAN, P. S., 1986, Macrolide antibiotics inhibit the degradation of the glucocorticoid-responsive cytochrome P-450p in rat hepatocytes in vivo and in primary monolayer culture. Journal of Biological Chemistry, 261, 6264–6271.
   PubMed Web of Science ®Google Scholar
• YEOWELL, H. N., WAXMAN, D. J., WADHERA, A. and GOLDSTEIN, J. A., 1987, Suppression of the constitutive, male-specific rat hepatic cytochrome P-450 2c and its mRNA by 3,4,5,3',4',5"-hexachlorobiphenyl and 3-methylcholanthrene. Molecular Pharmacology, 32, 340–347.
   PubMed Web of Science ®Google Scholar